Evidence Synthesis
AMRAFIN experienced a 7.19% increase in its gross margin, accelerating from 2.37% in the previous quarter.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 6 Sept 2026, 00:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AMRAFIN experienced a 7.19% increase in its gross margin, accelerating from 2.37% in the previous quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 7.19 % | 2.37 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.37 % | 3.73 | ▼ |
| REVENUE_GROWTH_YOY | -32.3 % | 1,263.7 | ▼ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 1,200 shares | 800 | ▲ |
| CLOSE_PRICE | 23.7 INR | 23.7 | - |